← Back to all trials
Completed
NCT05208697
Tele-Harm Reduction
Conditions: IV Drug Usage, HIV Infections, Hepatitis C
Sex: All
Ages: 18 Years – N/A
Healthy volunteers: No
Phase: NA
Enrollment: 100
Sponsor: University of Miami
Location: Care Resource The SPOT Fort Lauderdale Florida
Summary
The purpose of this study is to test 2 different methods for offering medications that treat HIV, cure Hepatitis C Virus (HCV) (if applicable) and treat substance use disorder (if desired) to people who inject drugs.
Eligibility Criteria
Inclusion Criteria:
* age 18 or older
* able to speak English
* enrolled in IDEA Miami or IDEA Tampa SSPs
* injection drug use in past 12 months by self-report
* willing and able to sign informed consent, provide locator information and medical records release
* testing reactive for HIV by rapid test
* HIV RNA\>200 copies/ml as determined by on-site labs or abstracted medical records (result within 3 months of randomization date)
Exclusion Criteria:
* testing HIV negative via rapid test
* receipt of THR intervention in the past 6 months
* inability to provide informed consent
* planning to leave the area within 12 months
* Principal or site investigator discretion
* currently in prison or jail
* Enrollment in Clinical Trials Network 121
Source: ClinicalTrials.gov (NCT05208697). StuddyBuddy aggregates publicly available trial information.